Teclistamab impairs detection of BCMA CAR-T cells

Blood Adv. 2023 Aug 8;7(15):3842-3845. doi: 10.1182/bloodadvances.2023009714.

Bettina Glatte¹, Kerstin Wenk¹, Anja Grahnert^{1

2}, Maik Friedrich¹, Maximilian Merz³, Vladan Vucinic³, Luise Fischer³, Kristin Reiche^{1

2}, Miriam Alb⁴, Michael Hudecek⁴, Paul Franz², Stephan Fricke², Uwe Platzbecker³, Ulrike Koehl^{1

2

5}, Ulrich Sack¹, Andreas Boldt¹, Sunna Hauschildt^{1

6}, Ronald Weiss^{1

2}

¹ Institute of Clinical Immunology, Medical Faculty, Leipzig University, Leipzig and University of Leipzig Medical Center, Leipzig, Germany.
² Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
³ Department of Hematology and Cell Therapy, Medical Faculty, Leipzig University, Leipzig and University of Leipzig Medical Center, Leipzig, Germany.
⁴ Department of Internal Medicine II, Cellular Immunotherapy, University Hospital Wuerzburg, Wuerzburg, Germany.
⁵ Institute for Cellular Therapeutics, Hannover Medical School, Hannover, Germany.
⁶ Institute of Biology, Faculty of Life Science, Leipzig University, Leipzig, Germany.

No abstract available

MeSH terms